Ischemia Modified Albumin Protein (IMA)
IMA
Origine: Humain
Hôte: Human
Native
> 90 %
SDS, WB, Imm, PC
-
- Antigène Tous les produits Ischemia Modified Albumin (IMA)
- Ischemia Modified Albumin (IMA)
- Type de proteíne
- Native
- Origine
- Humain
-
Source
- Human
- Application
- SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
- Pureté
- > 90 %
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Isoelectric Point:
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute in sterile PBS, pH 7.2 - pH 7.4.
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Agent conservateur
- ProClin
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
- Stock
- 4 °C,-80 °C
- Stockage commentaire
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- Ischemia Modified Albumin (IMA)
- Autre désignation
- Ischemia Modified Albumin (IMA Produits)
- Sujet
- Ischemia Modified Albumin is also called Human serum albumin. Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. It is soluble and monomeric. Albumin is synthesized in the liver as preproalbumin, which has an N-terminal peptide that is removed before the nascent protein is released from the rough endoplasmic reticulum. It has a molecular mass of 67 kDa. Human albumin is often used to replace lost fluid and help restore blood volume in trauma, burns and surgery patients. A Cochrane systematic review[6] of 37 trials found no evidence that albumin, compared with cheaper alternatives such as saline, reduces the risk of dying.
- Poids moléculaire
- 68 kDa
-
Vous êtes ici:
